Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS

NCT03038906 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03038906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS
Lead sponsor
University of Washington
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
September 30, 2020
Enrollment
290 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, neuromyopathies